Related Experiment Video
Updated: Aug 30, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
[Cerebral amyloid angiopathy as a cause of strokes]
Eleonora Jankowicz1, Wiesław Drozdowski
1Kliniki Neurologii AM w Białymstoku.
Insights
Cerebral amyloid angiopathy (CAA) involves amyloid buildup in brain arteries, mimicking Alzheimer's disease and causing recurrent cerebral hemorrhages. Diagnosis relies on autopsy or biopsy, with no current treatments, but avoiding anticoagulants is crucial.
Area of Science:
- Neurology
- Pathology
- Geriatrics
Context:
- Cerebral amyloid angiopathy (CAA) is a significant cerebrovascular condition in the elderly.
- It shares similarities with Alzheimer's disease pathology.
- CAA is the second leading cause of cerebral hemorrhage, particularly recurrent cases.
Purpose:
- To define cerebral amyloid angiopathy (CAA).
- To highlight its association with cerebral hemorrhages and other neurological dysfunctions.
- To emphasize diagnostic criteria and current management considerations.
Summary:
- CAA results from amyloid deposition in cerebral leptomeningeal and cortical arteries.
- It is linked to transient ischemic attacks, cerebral infarcts, and leukoencephalopathy.
- Definitive diagnosis requires autopsy or biopsy; probable diagnosis is clinical, based on superficial hemorrhages in elderly non-hypertensive individuals.
Impact:
- Understanding CAA is crucial for managing elderly patients with cerebrovascular events.
- Avoiding anticoagulants and antiplatelet drugs is vital to prevent hemorrhage in CAA patients.
- Further research is needed for effective CAA treatment strategies.
Abstract:
Cerebral amyloid angiopathy (CAA), a condition affecting the elderly in a way similar to that of Alzheimer's disease, results from amyloid deposition within small and medium arteries of the cerebral leptomeninges and cerebral cortex. Next to atheromatosis, amyloidosis is the second most frequent cause of cerebral haemorrhage, especially recurrent. The most recent publications suggest that amyloidosis may also cause transient ischaemic attacks (TIA), cerebral infarcts, Binswanger's type leukoencephalopathy, symptoms resembling these of cerebral pseudotumour, and other dysfunctions. A definite diagnosis of cerebral amyloid angiopathy may be determined by autopsy, and sometimes intravital cerebral biopsy is performed. A clinical diagnosis of probable CAA is based on the presence of multiple superficial haemorrhages in the elderly people without hypertension. No CAA treatment methods are known yet. However, to prevent haemorrhages in CAA it is important that anticoagulants and antiplatelet drugs should be avoided in the treatment of cerebral and other ischaemic disorders, because of an increased risk for haemorrhage.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Cerebral Edema ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Dementia l: Introduction

